AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Lansoloc

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

101 API Suppliers, 39 USDMF, 26 CEP/COS, 18 JDMF, 22 EU WC, 18 KDMF, 21 NDC API, 54 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

769 FDF Dossiers, 68 FDA Orange Book, 462 Europe, 27 Canada, 66 Australia, 32 South Africa, 114 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 30MG, CAPSULE, DELAYED REL PELLETS;ORAL - 15MG, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 8 Evonik, 8 Rochem International Inc, 23 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 2 Clariant, 14 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 45 Thickeners and Stabilizers, 41 Controlled & Modified Release, 39 Taste Masking, 36 Solubilizers, 34 Direct Compression, 29 Film Formers & Plasticizers, 24 Disintegrants & Superdisintegrants, 24 Granulation, 23 Topical, 22 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 21 Parenteral, 18 Co-Processed Excipients, 12 Emulsifying Agents, 9 Rheology Modifiers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

200 News #PharmaBuzz

200 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 408 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

18 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 27 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 15 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
24/02/2025	Metrochem API Private Limited	India	METROCHEM API PRIVATE LTD	35485	LANSOPRAZOLE USP	2020-12-22	Active	II	N/A
24/02/2025	Moehs Iberica	Spain	MOEHS IBERICA SL	17819	LANSOPRAZOLE	2004-11-02	Active	II	Complete	2017-12-01	2017-10-05

Lansoloc

Lansoloc

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

101 API Suppliers

39 USDMF

26 CEP/COS

18 JDMF

22 EU WC

18 KDMF

21 NDC API

54 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

769 FDF Dossiers

68 FDA Orange Book

462 Europe

27 Canada

66 Australia

32 South Africa

114 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 30MG

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

8 Evonik

8 Rochem International Inc

23 SPI Pharma

13 DKSH

1 Pharm-RX Chemical

8 Faran Shimi Pharmaceutical

2 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

8 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Pramukh Pharmachem

4 ACG Worldwide

10 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

26 BASF

1 Bioplus Life Sciences

2 Clariant

14 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

3 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

13 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

32 Kerry

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

40 Roquette

16 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons